News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Submissions are open for the EACR-Mark Foundation Postdoctoral Fellowships
Photo from EACR/LinkedIn
Jun 27, 2024, 15:03

Submissions are open for the EACR-Mark Foundation Postdoctoral Fellowships

The European Association for Cancer Research (EACR) shared on LinkedIn:

“Submissions are open for the EACR-Mark Foundation Postdoctoral Fellowships until 21 August! This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe.

Learn more.”

Source: EACR/LinkedIn

cancer EACR EACR-Mark Foundation European Association for Cancer Research OncoDaily Oncology
Blog
Jun 30, 2024, 02:46
Dana-Farber Cancer Institute - William Kaelin Jr. was recognized with the Stanley P. Reimann Honor Award
Blog
Jun 30, 2024, 02:36
IPOS2024 at MASCC2024
Blog
Jun 30, 2024, 02:25
Michael Jefford: Terrific presentation from Dr. Julia Lai-Kwon at MASCC24
Blog
Jun 30, 2024, 02:19
European Cancer Summit - from what could be... to what will be
Blog
Jun 30, 2024, 02:06
Susie Stanway: Cancer care in humanitarian settings: a focus on Africa
Insight
Jun 30, 2024, 00:34
A new analysis of the UK lung screening trials - Lung Cancer Policy Network
Blog
Jun 30, 2024, 00:31
Tihana Gašpert: Excited to host our first ECPP event of the year! Please join Amanda Balakirsky
Insight
Jun 30, 2024, 00:24
First Robotic Stereotactic Radiotherapy Program in the India Sub-Continent - Apollo Hospitals Karnataka
Blog
Jun 30, 2024, 00:23
Abstract titles for ASCOBT24 are now available!
Blog
Jun 29, 2024, 23:59
Tracey O'Brien: One of the greatest privileges of being a paediatric oncologist is witnessing the strength and resilience of young people
Blog
Jun 29, 2024, 23:44
Team Campbell Foundation is supporting the EPICC grant for combining genomics and immunotherapy - St. Baldrick's Foundation
Insight
Jun 29, 2024, 23:21
Andrea Morandi: A critical vulnerability in triple-negative breast cancer